Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1983 1
1984 2
1985 4
1986 3
1987 4
1988 10
1989 2
1990 1
1991 5
1992 3
1993 6
1994 2
1995 6
1996 2
1997 3
1998 2
1999 5
2000 5
2001 7
2002 11
2003 5
2004 2
2005 9
2006 12
2007 11
2008 15
2009 15
2010 17
2011 16
2012 25
2013 15
2014 28
2015 23
2016 22
2017 27
2018 25
2019 27
2020 22
2021 32
2022 32
2023 29
2024 26
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

465 results

Results by year

Filters applied: . Clear all
Page 1
Cell-free DNA whole-genomes reveal chromosomal rearrangements associated with heterogeneity and stem cell-like castration-resistant prostate cancer.
Roskes ML, Martinez-Fundichely A, Cohen S, Balaban M, Wong CK, Li W, Gonzalez TA, Tehim AB, Xu H, ElNaggar S, Myers M, Bareja R, Dorsaint P, Gorski K, Asad M, Assaad MA, Robinson BD, Sigouros M, Barnett E, Manohar J, Tagawa S, Nanus D, Molina A, Nauseef JT, Sternberg CN, Mosquera JM, Scher HI, Sboner A, Raphael BJ, Chen Y, Khurana E. Roskes ML, et al. Among authors: sternberg cn. medRxiv [Preprint]. 2025 Jul 2:2025.07.01.25330467. doi: 10.1101/2025.07.01.25330467. medRxiv. 2025. PMID: 40630580 Free PMC article. Preprint.
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution.
Nagar H, Diven MA, Rippon B, Barbieri CE, Hu JC, Scherr DS, Yadav P, Tshering L, Chandrasekhar S, Wolfe S, Pennell R, Coonce M, Chen SL, Formenti SC, Strong P, Davicioni E, Molina AM, Nanus DM, Nauseef JT, Sternberg CN, Zhou XK, Lei W, Osborne JR, Marciscano AE, Tagawa ST. Nagar H, et al. Among authors: sternberg cn. Eur Urol Oncol. 2025 Jun 9:S2588-9311(25)00152-X. doi: 10.1016/j.euo.2025.05.014. Online ahead of print. Eur Urol Oncol. 2025. PMID: 40494733
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Long-term Outcomes from the JAVELIN Bladder 100 Trial in Patients with Nonvisceral or Lymph Node-only Disease.
Bellmunt J, Powles T, Park SH, Voog E, Valderrama BP, Gurney H, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N, Sternberg CN, Aragon-Ching JB, Petrylak DP, Climent Duran MA, Tyroller K, Hoffman J, Jacob N, Grivas P, Gupta S. Bellmunt J, et al. Among authors: sternberg cn. Eur Urol. 2025 Jun 3:S0302-2838(25)00295-7. doi: 10.1016/j.eururo.2025.05.017. Online ahead of print. Eur Urol. 2025. PMID: 40467365 Free article.
Clinical trials corner issue 11(1).
Agarwal PK, Sternberg CN. Agarwal PK, et al. Among authors: sternberg cn. Bladder Cancer. 2025 Mar 25;11(1):23523735241309418. doi: 10.1177/23523735241309418. eCollection 2025 Jan-Mar. Bladder Cancer. 2025. PMID: 40144577 Free PMC article. No abstract available.
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial.
Powles T, Tagawa S, Vulsteke C, Gross-Goupil M, Park SH, Necchi A, De Santis M, Duran I, Morales-Barrera R, Guo J, Sternberg CN, Bellmunt J, Goebell PJ, Kovalenko M, Boateng F, Sierecki M, Wang L, Sima CS, Waldes J, Loriot Y, Grivas P. Powles T, et al. Among authors: sternberg cn. Ann Oncol. 2025 May;36(5):561-571. doi: 10.1016/j.annonc.2025.01.011. Epub 2025 Feb 11. Ann Oncol. 2025. PMID: 39934055 Clinical Trial.
Unusual Presentation of Advanced Urothelial Cancer in a Young Patient.
Guevara D, Shin N, Boiko A, Valiev I, Elsaeed AG, Mosquera JM, Al Assaad M, Manohar J, Sigouros M, Zaichikova A, Fomchenkova V, Yunusova L, Smirnova S, Elemento O, Nanus D, Sternberg CN. Guevara D, et al. Among authors: sternberg cn. Anticancer Res. 2025 Feb;45(2):613-618. doi: 10.21873/anticanres.17448. Anticancer Res. 2025. PMID: 39890191
Mesonephric Adenocarcinoma in a Young Male Patient.
Guevara D, Shin N, Boiko A, Valiev I, Elsaeed AG, Mosquera JM, Al Assaad M, Manohar J, Sigouros M, Zaichikova A, Fomchenkova V, Yunusova L, Smirnova S, Elemento O, Nauseef J, Sternberg CN. Guevara D, et al. Among authors: sternberg cn. Anticancer Res. 2025 Feb;45(2):619-623. doi: 10.21873/anticanres.17449. Anticancer Res. 2025. PMID: 39890190
Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial.
de Bono JS, He M, Shi Z, Nowicka M, Bracarda S, Sternberg CN, Chi KN, Olmos D, Sandhu S, Massard C, Matsubara N, Chen G, Bienz NS, Canter D, Wongchenko M, Sweeney C. de Bono JS, et al. Among authors: sternberg cn. Eur Urol. 2025 Jun;87(6):672-682. doi: 10.1016/j.eururo.2024.12.015. Epub 2025 Jan 30. Eur Urol. 2025. PMID: 39884884 Free article. Clinical Trial.
Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study.
Grivas P, Barata P, Moon H, Gupta S, Hutson T, Sternberg CN, Brown JR, Dave V, Downey C, Shillington AC, Katzenstein HM, Kirker M, Hanson S, Liu FX, Morris V, Bhanegaonkar A, Sonpavde GP. Grivas P, et al. Among authors: sternberg cn. Clin Genitourin Cancer. 2024 Dec;22(6):102238. doi: 10.1016/j.clgc.2024.102238. Epub 2024 Oct 17. Clin Genitourin Cancer. 2024. PMID: 39532048 Free article.
465 results